Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity.

Palakurthi S, Kuraguchi M, Zacharek SJ, Zudaire E, Huang W, Bonal DM, Liu J, Dhaneshwar A, DePeaux K, Gowaski MR, Bailey D, Regan SN, Ivanova E, Ferrante C, English JM, Khosla A, Beck AH, Rytlewski JA, Sanders C, Laquerre S, Bittinger MA, Kirschmeier PT, Packman K, Janne PA, Moy C, Wong KK, Verona RI, Lorenzi MV.

Cancer Immunol Res. 2019 Sep;7(9):1457-1471. doi: 10.1158/2326-6066.CIR-18-0595. Epub 2019 Jul 22.

PMID:
31331945
2.

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O'Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM.

Nat Med. 2019 Mar;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Epub 2019 Feb 11.

3.

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma.

Agdashian D, ElGindi M, Xie C, Sandhu M, Pratt D, Kleiner DE, Figg WD, Rytlewski JA, Sanders C, Yusko EC, Wood B, Venzon D, Brar G, Duffy AG, Greten TF, Korangy F.

Cancer Immunol Immunother. 2019 Apr;68(4):599-608. doi: 10.1007/s00262-019-02299-8. Epub 2019 Jan 28.

4.

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire.

Tarhini A, Lin Y, Lin H, Rahman Z, Vallabhaneni P, Mendiratta P, Pingpank JF, Holtzman MP, Yusko EC, Rytlewski JA, Rao UNM, Ferris RL, Kirkwood JM.

J Immunother Cancer. 2018 Oct 23;6(1):112. doi: 10.1186/s40425-018-0428-5.

5.

T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma.

Hopkins AC, Yarchoan M, Durham JN, Yusko EC, Rytlewski JA, Robins HS, Laheru DA, Le DT, Lutz ER, Jaffee EM.

JCI Insight. 2018 Jul 12;3(13). pii: 122092. doi: 10.1172/jci.insight.122092.

6.

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.

Wrangle JM, Velcheti V, Patel MR, Garrett-Mayer E, Hill EG, Ravenel JG, Miller JS, Farhad M, Anderton K, Lindsey K, Taffaro-Neskey M, Sherman C, Suriano S, Swiderska-Syn M, Sion A, Harris J, Edwards AR, Rytlewski JA, Sanders CM, Yusko EC, Robinson MD, Krieg C, Redmond WL, Egan JO, Rhode PR, Jeng EK, Rock AD, Wong HC, Rubinstein MP.

Lancet Oncol. 2018 May;19(5):694-704. doi: 10.1016/S1470-2045(18)30148-7. Epub 2018 Apr 5.

7.

TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma.

Brown JA, Yonekubo Y, Hanson N, Sastre-Perona A, Basin A, Rytlewski JA, Dolgalev I, Meehan S, Tsirigos A, Beronja S, Schober M.

Cell Stem Cell. 2017 Nov 2;21(5):650-664.e8. doi: 10.1016/j.stem.2017.10.001.

8.

Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.

Lavin Y, Kobayashi S, Leader A, Amir ED, Elefant N, Bigenwald C, Remark R, Sweeney R, Becker CD, Levine JH, Meinhof K, Chow A, Kim-Shulze S, Wolf A, Medaglia C, Li H, Rytlewski JA, Emerson RO, Solovyov A, Greenbaum BD, Sanders C, Vignali M, Beasley MB, Flores R, Gnjatic S, Pe'er D, Rahman A, Amit I, Merad M.

Cell. 2017 May 4;169(4):750-765.e17. doi: 10.1016/j.cell.2017.04.014.

9.

Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs.

Rytlewski JA, Alejandra Aldon M, Lewis EW, Suggs LJ.

Microvasc Res. 2015 May;99:26-35. doi: 10.1016/j.mvr.2015.02.005. Epub 2015 Feb 21.

10.

Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells.

Chung E, Rytlewski JA, Merchant AG, Dhada KS, Lewis EW, Suggs LJ.

Acta Biomater. 2015 Apr;17:78-88. doi: 10.1016/j.actbio.2015.01.012. Epub 2015 Jan 16.

11.

RNAi in the mouse: rapid and affordable gene function studies in a vertebrate system.

Rytlewski JA, Beronja S.

Wiley Interdiscip Rev Dev Biol. 2015 Jan-Feb;4(1):45-57. doi: 10.1002/wdev.164. Epub 2014 Nov 14. Review.

PMID:
25399926
12.

Sleep syncope: treatment with a permanent pacemaker.

Rytlewski JA, Lee JT, Raj SR.

Pacing Clin Electrophysiol. 2012 Jul;35(7):e206-9. doi: 10.1111/j.1540-8159.2012.03365.x. Epub 2012 Mar 20.

13.

Three-dimensional image quantification as a new morphometry method for tissue engineering.

Rytlewski JA, Geuss LR, Anyaeji CI, Lewis EW, Suggs LJ.

Tissue Eng Part C Methods. 2012 Jul;18(7):507-16. doi: 10.1089/ten.TEC.2011.0417. Epub 2012 Feb 17.

14.

Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.

McGuire DK, Winterfield JR, Rytlewski JA, Ferrannini E.

Diab Vasc Dis Res. 2008 Mar;5(1):59-66. doi: 10.3132/dvdr.2008.011. Review.

PMID:
18398815

Supplemental Content

Loading ...
Support Center